Loop Capital reaffirms buy rating, $75 PT on Tempur Sealy stock post-FTC lawsuit

On Tuesday, Loop Capital maintained its positive stance on Tempur Sealy (NYSE:TPX) International Inc. (NYSE:TPX), reaffirming a Buy rating and a $75.00 price target for the company's shares. The endorsement follows Tempur Sealy's recent conference call addressing the Federal Trade Commission (FTC) lawsuit.

The analyst from Loop Capital expressed confidence in the stock, suggesting that Tempur Sealy is a solid investment whether or not the pending acquisition of Mattress Firm is finalized. The $75 price target set by the firm takes into account the anticipated value addition from the Mattress Firm acquisition, which is expected to commence in 2025.

The valuation of Tempur Sealy by Loop Capital is based on a multiple of 7 times the enterprise value to estimated EBITDA for the year 2025, assuming the acquisition is completed. If the deal does not go through, the multiple is projected to be less than 10 times. Currently, Tempur Sealy's stand-alone price-to-earnings ratio for the year 2024 stands at 16 times.

Loop Capital's published estimates for Tempur Sealy are based on the company's stand-alone performance to facilitate comparison with the consensus. The analyst noted that the expectation of a legal challenge to the Mattress Firm acquisition was anticipated given the FTC's current opposition to mergers. The firm believes that Tempur Sealy has strategically prepared for this scenario.

In other recent news, Tempur Sealy International Inc. finds itself at the center of several significant developments. Despite the FTC lawsuit, Piper Sandler maintains its Overweight rating on Tempur Sealy, indicating the firm's belief in the company's appeal regardless of the acquisition's outcome.

In addition to the merger controversy, Tempur Sealy has initiated a joint healthcare venture with Tempus AI, backed by SoftBank (TYO:9984) Group. This partnership aims to leverage artificial intelligence to enhance treatment recommendations by analyzing personal medical data.

Turning to financials, Tempur Sealy reported stable Q1 2024 results with net sales reaching $1.2 billion and an adjusted EPS of $0.50. The company's adjusted EBITDA remained consistent at $198 million compared to the same period last year.

These recent developments underscore the dynamic nature of Tempur Sealy's operations amid evolving market conditions.

InvestingPro Insights

Tempur Sealy International Inc. (NYSE:TPX) has demonstrated a notable performance with key financial metrics indicating a solid business foundation. According to real-time data from InvestingPro, Tempur Sealy boasts a market capitalization of $8.24 billion and maintains a Price/Earnings (P/E) ratio of 22.63 for the last twelve months as of Q1 2024. While the company's revenue showed a slight increase of 0.35% during the same period, investors should note the high Price/Book multiple of 25.23, which indicates a premium market valuation relative to the company's book value.

InvestingPro Tips suggest that Tempur Sealy has raised its dividend for three consecutive years, reflecting a commitment to returning value to shareholders. This is complemented by a dividend growth of 18.18% over the last twelve months as of Q1 2024, with a current dividend yield of 1.1%. Despite recent stock price volatility, analysts predict profitability for the company this year, a sentiment supported by its strong return over the last five years.

For readers seeking more in-depth analysis, there are additional InvestingPro Tips available for Tempur Sealy, which can be accessed by visiting https://www.investing.com/pro/TPX. To enhance your investment research experience, use the coupon code PRONEWS24 to get up to 10% off a yearly Pro and a yearly or biyearly Pro+ subscription. Discover valuable insights that could further inform your investment decisions regarding Tempur Sealy International Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.